109 related articles for article (PubMed ID: 20534369)
1. Prevention and cure of rheumatoid arthritis: is it possible?
Machold KP
Best Pract Res Clin Rheumatol; 2010 Jun; 24(3):353-61. PubMed ID: 20534369
[TBL] [Abstract][Full Text] [Related]
2. Innovative treatment strategies for patients with rheumatoid arthritis.
van der Kooij SM; Allaart CF; Dijkmans BA; Breedveld FC
Curr Opin Rheumatol; 2008 May; 20(3):287-94. PubMed ID: 18388520
[TBL] [Abstract][Full Text] [Related]
3. Unmet needs in rheumatoid arthritis.
Bykerk V
J Rheumatol Suppl; 2009 Jun; 82():42-6. PubMed ID: 19509330
[TBL] [Abstract][Full Text] [Related]
4. Activity assessments in rheumatoid arthritis.
Smolen JS; Aletaha D
Curr Opin Rheumatol; 2008 May; 20(3):306-13. PubMed ID: 18388523
[TBL] [Abstract][Full Text] [Related]
5. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
[TBL] [Abstract][Full Text] [Related]
6. [Modern treatment of rheumatoid arthritis].
Surányi P
Orv Hetil; 2005 Oct; 146(40):2059-65. PubMed ID: 16259334
[TBL] [Abstract][Full Text] [Related]
7. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
8. [Monitoring disease activity, adjustment of conventional treatment and prognosis in rheumatoid arthritis].
Grazio S
Reumatizam; 2008; 55(2):45-52. PubMed ID: 19024274
[TBL] [Abstract][Full Text] [Related]
9. Methods used to assess remission and low disease activity in rheumatoid arthritis.
Ometto F; Botsios C; Raffeiner B; Sfriso P; Bernardi L; Todesco S; Doria A; Punzi L
Autoimmun Rev; 2010 Jan; 9(3):161-4. PubMed ID: 19602456
[TBL] [Abstract][Full Text] [Related]
10. Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study.
Allaart CF; Breedveld FC; Dijkmans BA
J Rheumatol Suppl; 2007 Nov; 80():25-33. PubMed ID: 17985420
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
Ogrendik M
Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
[TBL] [Abstract][Full Text] [Related]
12. Early rheumatoid arthritis.
Mitchell KL; Pisetsky DS
Curr Opin Rheumatol; 2007 May; 19(3):278-83. PubMed ID: 17414956
[TBL] [Abstract][Full Text] [Related]
13. Assessment and management of rheumatoid arthritis.
Haraoui B
J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
[TBL] [Abstract][Full Text] [Related]
14. [Course, follow-up and prognosis of rheumatoid polyarthritis].
Combe B
Rev Prat; 1997 Nov; 47(18):2017-21. PubMed ID: 9501619
[TBL] [Abstract][Full Text] [Related]
15. A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.
Verstappen SM; van Albada-Kuipers GA; Bijlsma JW; Blaauw AA; Schenk Y; Haanen HC; Jacobs JW;
Ann Rheum Dis; 2005 Jan; 64(1):38-43. PubMed ID: 15130899
[TBL] [Abstract][Full Text] [Related]
16. Adalimumab for early rheumatoid arthritis.
Bykerk VP
Expert Rev Clin Immunol; 2008 Mar; 4(2):157-63. PubMed ID: 20477047
[TBL] [Abstract][Full Text] [Related]
17. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
Sesin CA; Bingham CO
Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
[TBL] [Abstract][Full Text] [Related]
18. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
Wells GA; Boers M; Shea B; Brooks PM; Simon LS; Strand CV; Aletaha D; Anderson JJ; Bombardier C; Dougados M; Emery P; Felson DT; Fransen J; Furst DE; Hazes JM; Johnson KR; Kirwan JR; Landewé RB; Lassere MN; Michaud K; Suarez-Almazor M; Silman AJ; Smolen JS; Van der Heijde DM; van Riel PL; Wolfe F; Tugwell PS
J Rheumatol; 2005 Oct; 32(10):2016-24. PubMed ID: 16206362
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R
Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
[TBL] [Abstract][Full Text] [Related]
20. [Management of patients with rheumatoid arthritis].
Thomas D
Ther Umsch; 2005 May; 62(5):281-4. PubMed ID: 15945217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
